Authors

1 Department of Pharmacology and Therapeutics, Usmanu Danfodiyo University, Sokoto, Nigeria

2 Department of Community Medicine, Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria

Abstract

Objective: Objective of this study was to assess the attitude of nurses and pharmacists 
towards adverse drug reactions (ADRs) reporting.
Methods: The questionnaire was designed based on extended “Inman seven deadly 
sins.” Two hundred and seventy‑two respondents were selected by stratified sampling 
technique. The questionnaires were delivered to the respondents at their places of 
practice. The data generated were analyzed by Sigma XL Software Inc.
Findings: There was no statistically significant relationship between demographic 
profiles and reporting attitude except for qualification. On extended “Inman seven 
deadly sins” awareness of reporting protocol and nearby center for ADRs reporting 
were low 27.3 and 7.5%, respectively. However, respondents’ score on components of 
attitude of ADRs reporting is generally encouraging. On comparative basis, no statistical 
significance exists between pharmacists and nurses.
Conclusion: The study showed that attitude of respondents towards ADRs reporting is 
good. However, there is a need for targeted health education intervention among these 
cadres of health‑care professionals, especially on aspects of awareness of reporting 
protocol and reporting center.

Keywords

1. World Health Organisation. The safety of medicines in public 
health programmes: Pharmacovigilance an essential tool. 
The Uppsala Monitoring; 2006. www.who.int/medicines/
areas/quality_safety_efficacy/pharmacovigilance_B.pdf
[Last accessed on 2015 Apr 15].
2. Pirmohamed M, James S, Meakin S, Green C, Scott AK, 
Walley TJ, et al. Adverse drug reactions as cause of admission 
to hospital: Prospective analysis of 18 820 patients. BMJ 
2004;329:15‑9.
3. Ye X, Fu Z, Wang H, Du W, Wang R, Sun Y, et al. Acomputerized 
system for signal detection in spontaneous reporting system of 
Shanghai China. Pharmacoepidemiol Drug Saf 2009;18:154‑8.
4. Brvar M, Fokter N, Bunc M, Mozina M. The frequency of 
adverse drug reaction related admissions according to method 
of detection, admission urgency and medical department 
specialty. BMC Clin Pharmacol 2009;9:8.
5. Oshikoya KA, Chukwura H, Njokanma OF, Senbanjo IO, Ojo I. 
Incidence and cost estimate of treating pediatric adverse drug 
reactions in Lagos, Nigeria. Sao Paulo Med J 2011;129:153‑64.
6. Inman WH. Attitudes to adverse drug reaction reporting. Br 
J Clin Pharmacol 1996;41:434‑5.
7. Hajebi G, Mortazavi SA, Salamzadeh J, Zian A. A survey 
of knowledge, attitude and practice of nurses towards 
pharamacovigilance in Taleqani hospital. Iran J Pharm Res 
2010;9:199‑206.
8. Desai CK, Iyer G, Panchal J, Shah S, Dikshit RK. An evaluation 
of knowledge, attitude, and practice of adverse drug reaction 
reporting among prescribers at a tertiary care hospital. 
Perspect Clin Res 2011;2:129‑36.
9. Smith CC, Bennett PM, Pearce HM, Harrison PI, Reynolds DJ, 
Aronson JK, et al. Adverse drug reactions in a hospital general 
medical unit meriting notification to the Committee on Safety 
of Medicines. Br J Clin Pharmacol 1996;42:423‑9